| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/04/2007 | US20070003566 Polyepitope carrier protein |
| 01/04/2007 | US20070003564 Diluent for immunohistochemistry |
| 01/04/2007 | US20070003560 Humanized monoclonal antibodies that protect against shiga toxin induced disease |
| 01/04/2007 | US20070003555 Heat shock protein binding fragments of CD91, and uses thereof |
| 01/04/2007 | US20070003553 Anticoagulant agents useful in treatment of thrombosis |
| 01/04/2007 | US20070003548 Anti-TNF antibodies, compositions, methods and uses |
| 01/04/2007 | US20070003544 Combination therapy for treatment of autoimmune diseases using b- cell depleting/immunoregulatory antibody combination |
| 01/04/2007 | US20070003543 Low dose histone peptide treatment for autoimmune disorders |
| 01/04/2007 | US20070003542 Methods for treating diseases or conditions with peptide constructs |
| 01/04/2007 | US20070003541 Methods and compositions for therapeutics |
| 01/04/2007 | US20070003540 Stem cells having increased sensitivity to sdf-1 and methods of generating and using same |
| 01/04/2007 | US20070003539 Thrombotic or thromboembolic disorders; factor VIIa inhibitors; 2-(1-Amino-isoquinolin-6-ylamino)-N-(2-cyclobutanesulfonyl-benzyl)-2-(5-ethoxy-2-fluoro-4-methoxy-phenyl)-N-methyl-acetamide trifluoroacetic acid salt |
| 01/04/2007 | US20070003538 Antimicrobial compositions and uses thereof |
| 01/04/2007 | US20070003537 Cytotoxic ribonuclease variants |
| 01/04/2007 | US20070003536 Using a grapefruit, grape seed and green tea extract comprising superoxide dismutase, glutathione, tetrahydrodiferuloylmethane, flavonoid, tocopherol and tocopheryl acetate as part of lotion to treat and prevent damaged skin |
| 01/04/2007 | US20070003535 Methods and compositions for derepression of IAP-inhibited caspase |
| 01/04/2007 | US20070003534 Comprehensive analysis of transcription control factor complexes in a mouse brain cDNA library with c-Jun as a bait by using the cotranslation selection and screening of in vitro virus (IVV) and the C-terminal labeling method |
| 01/04/2007 | US20070003528 Intracoronary device and method of use thereof |
| 01/04/2007 | US20070003524 Targeted retrograde gene delivery to motor neurons |
| 01/04/2007 | US20070003523 Short interference ribonuclic acids for treatment and prevention of diabetic retinopathy, age related macular degeneration and cancer; gene expression inhibition |
| 01/04/2007 | US20070003521 Expression vectors containing hybrid ubiquitin promoters |
| 01/04/2007 | US20070003517 administering to a target tissue a nucleic acid that encodes a polypeptide inhibiting c-Jun NH2-terminal kinase (JNK) activity in a target tissue; Parkinson's and Alzheimer's disease; arthritis |
| 01/04/2007 | US20070003516 Compounds, compositions and methods for the treatment of poxvirus infections |
| 01/04/2007 | US20070003515 Method of inducing memory b cell development and terminal differentiation |
| 01/04/2007 | US20070003514 Mono-and bi-functional antibody conjugates as effective adjuvants of protein vaccination |
| 01/04/2007 | US20070003503 Tissue enhancement implant and method |
| 01/04/2007 | US20070003491 administering polylysine to mammals as dietetics, for prevention and/or treatment of obesity |
| 01/04/2007 | US20070003486 Ointment wound spray |
| 01/04/2007 | US20070003480 Liposomal composition comprising haptotactic peptides |
| 01/04/2007 | CA2614358A1 Agonistic and antagonistic peptide mimetics of the vegf alpha-helix binding region for use in therapy |
| 01/04/2007 | CA2614103A1 Additional arginines in vimentin polypeptides for diagnosing rheumatic diseases |
| 01/04/2007 | CA2613903A1 Exendin 4 polypeptide fragments and use thereof |
| 01/04/2007 | CA2613737A1 Recombinant interferon .alpha.2 (if.alpha.2) mutants |
| 01/04/2007 | CA2613705A1 Compositions and methods for less immunogenic pr0tein-lip1d complexes |
| 01/04/2007 | CA2613654A1 Hecgf-1 related polymorphisms and applications thereof |
| 01/04/2007 | CA2613494A1 Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain (plad) of tumor necrosis factor receptors |
| 01/04/2007 | CA2613378A1 Lysozyme-based food stuff |
| 01/04/2007 | CA2613193A1 Thrombospondin-1 derived peptides and treatment methods |
| 01/04/2007 | CA2613126A1 Use of mas g-protein-coupled receptor agonists and antagonists as apoptotic activity modulators for prevention and treatment of diseases |
| 01/04/2007 | CA2613082A1 Method for identifying modulators of rufy2 useful for treating alzheimer's disease |
| 01/04/2007 | CA2613028A1 Peptidic antagonists of class iii semaphorins/neuropilins complexes |
| 01/04/2007 | CA2610720A1 Treatment of fungal and/or protist infections |
| 01/04/2007 | CA2610484A1 Methods for the preparation of 9-deazapurine derivatives |
| 01/04/2007 | CA2609954A1 Agent for ameliorating heavy metal-induced disorders, and medicinal composition, food and cosmetic containing the same |
| 01/03/2007 | EP1739186A1 Method of screening compound capable of accelerating or inhibiting apoptosis, apoptosis accelerator and apoptosis inhibitor |
| 01/03/2007 | EP1739178A2 Delivery of trefoil peptides |
| 01/03/2007 | EP1739177A1 Antibodies against interferon alpha/beta receptor |
| 01/03/2007 | EP1739171A1 Novel gene participating in epidermal differentiation and use thereof |
| 01/03/2007 | EP1739091A1 Trefoil peptide dimer |
| 01/03/2007 | EP1739090A2 Interferon-beta fusion proteins and uses |
| 01/03/2007 | EP1739082A1 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 01/03/2007 | EP1738763A1 Use of complement inhibitory proteins to treat spinal cord injury |
| 01/03/2007 | EP1738762A1 Preventive/remedy for diabetic complications using oligopeptide |
| 01/03/2007 | EP1737983A2 Method of inducing immunity against stratum corneum chymotrytic enzyme |
| 01/03/2007 | EP1737961A1 Modified bouganin proteins, cytotoxins and methods and uses thereof |
| 01/03/2007 | EP1737959A2 Stabilised tat antigen and the use thereof for anti-hiv vaccination |
| 01/03/2007 | EP1737954A2 Recombinant chondroitinase abc i and uses thereof |
| 01/03/2007 | EP1737953A2 Adamts-8 proteins and uses thereof |
| 01/03/2007 | EP1737948A2 Methods of promoting cardiac cell proliferation |
| 01/03/2007 | EP1737888A2 Erythropoietin protein variants |
| 01/03/2007 | EP1737886A2 Compounds that block the c5a receptor and their use in therapy |
| 01/03/2007 | EP1737884A1 Alpha helical mimics, their uses and methods for their production |
| 01/03/2007 | EP1737883A2 Synthetic peptides containing the motif "ywwlxp" as anthrax toxin antidotes |
| 01/03/2007 | EP1737882A1 Peptide inhibitors of metalloproteinase activity |
| 01/03/2007 | EP1737881A2 Novel compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 01/03/2007 | EP1737821A1 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 01/03/2007 | EP1737499A2 Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor |
| 01/03/2007 | EP1737498A2 Zinc finger proteins for treatment of neuropathic pain |
| 01/03/2007 | EP1737496A2 Novel g-csf conjugates |
| 01/03/2007 | EP1737493A2 Inhibitors of insulin-like growth factor receptor -1 for inhibiting tumour cell growth |
| 01/03/2007 | EP1737491A2 MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERS |
| 01/03/2007 | EP1737485A2 Mucinous glycoprotein (muc-1) vaccine |
| 01/03/2007 | EP1737484A1 Combination dosing regimen for erythropoietin |
| 01/03/2007 | EP1737483A2 Cell death modulation via antagonists of fasl and fas activation |
| 01/03/2007 | EP1737482A2 Compositions and methods for treating diseases |
| 01/03/2007 | EP1737481A2 Peptides of il1 beta and tnf alpha and method of treatment using same |
| 01/03/2007 | EP1737480A2 Pharmaceutical combined preparation containing a therapeutic protein |
| 01/03/2007 | EP1737479A1 Therapeutic administration of the scrambled anti-angiogenic peptide c16y |
| 01/03/2007 | EP1737476A2 Materials and method for promotion of nerve regeneration |
| 01/03/2007 | EP1737453A2 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of skin diseases or disorders |
| 01/03/2007 | EP1737425A1 Composition comprising colony stimulating factor for treatment of a localised bacterial infection and bacterial related disease |
| 01/03/2007 | EP1660099A4 Intravascular delivery of non-viral nucleic acid |
| 01/03/2007 | EP1633394B1 Combined pharmaceutical preparations for the treatment of cancer, containing glutaminase and antineoplastic anthracyclines or platinum compounds |
| 01/03/2007 | EP1585539A4 Wnt-1 inhibitory factor-1 (wif-1) molecules and uses thereof |
| 01/03/2007 | EP1578928A4 Metalloprotease activation of myostatin, and methods of modulating myostatin activity |
| 01/03/2007 | EP1572099A4 Screening and therapeutic methods relating to neurogenesis |
| 01/03/2007 | EP1539804B1 Synthesis and characterization of novel systems for guidance and vectorization of molecules of therapeutic interest towards target cells |
| 01/03/2007 | EP1527176B1 Further novel forms of interfering rna molecules |
| 01/03/2007 | EP1517619B1 Satiety inducing composition |
| 01/03/2007 | EP1511765B1 Par-2-activating peptide derivative and pharmaceutical composition using the same |
| 01/03/2007 | EP1448771B1 A method for combined parallel agent delivery and electroporation for cell structures and use thereof |
| 01/03/2007 | EP1448221B1 Injection solution comprising an lhrh antagonist |
| 01/03/2007 | EP1436389B1 Thrombin-cleavable chimeric proteins |
| 01/03/2007 | EP1430075B1 Antibacterial macrocycles |
| 01/03/2007 | EP1429731B1 Nanoparticulate insulin formulations |
| 01/03/2007 | EP1406507B1 Methods of extracting casein fractions from milk and caseinates and production of novel products |
| 01/03/2007 | EP1390403B1 Peptides derived from neural thread proteins and their medical use |
| 01/03/2007 | EP1385876B1 Gonococcal proteins and nucleic acids |
| 01/03/2007 | EP1337551B1 Substance p analogs for the treatment of cancer |
| 01/03/2007 | EP1334124B1 Diastereomeric peptides and pharmaceutical compositions comprising them |